ArticleJACC. Advances2025
Cardiac Medication Prescription Pattern and Association With Transplant-free Survival in the Adult Fontan Population.
Article in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Changes in pharmacotherapy in adults with Fontan circulation and associations with outcomes.International journal of cardiology. Congenital heart disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are limited data on the cardiac medications taken by patients with Fontan circulation in adult congenital heart disease (ACHD) clinics.
objectivesThe objectives of the study were to describe the type and frequency of cardiac medications prescribed to adults with Fontan circulation and assess for association between medication prescriptions/burden and transplant-free survival.
methodsA retrospective cohort study of adults with Fontan circulation followed in an outpatient ACHD clinic between 2009 and 2023 was performed. Demographics, clinical variables, and all prescribed outpatient cardiac medications were abstracted from the electronic medical record. The outcome of interest was transplant-free survival. Cox proportional hazards analysis was performed to determine the association between the medication type/burden and transplant-free survival.
resultsThere were 429 patients (55.2% male, 72.5% White, and 49.7% single left ventricle morphology) with median age 24 years (IQR: 22-29) at time of first clinic visit. The most prescribed medication classes were antiplatelet agents (74.6%) followed by angiotensin converting enzyme inhibitors or angiotensin receptor blockers (59.0%), anticoagulants (44.1%), loop diuretics (39.6%), metoprolol (32.2%), mineralocorticoid receptor antagonists (31.5%), antiarrhythmics (27.5%), and pulmonary vasodilators (16.1%). Being prescribed loop diuretic agents was associated with worse transplant-free survival (HR: 9.49, P < 0.001).
conclusionsWe report one of the first large-scale studies of prescription patterns in adult patients with Fontan circulation in a single ACHD clinic. We demonstrate an inverse association between loop diuretic prescriptions and transplant-free survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.